Iqvia Holdings (IQV) Other Non Operating Income (2012 - 2026)
Iqvia Holdings' (IQV) quarterly Other Non Operating Income came in at -$12.0 million in Q2 2026, down 9.09% year-over-year from -$13.2 million in Q2 2025, and down 71.43% quarter-over-quarter from -$7.0 million in Q1 2026.
Analysis
Iqvia Holdings (IQV) Other Non Operating Income (2012 - 2026) Analysis & Trends
Iqvia Holdings has disclosed Other Non Operating Income across 15 years of filings, most recently posting -$12.0 million for Q2 2026.
- In Q2 2026, Other Non Operating Income fell 9.09% year-over-year to -$12.0 million; the TTM figure through Jun 2026 stood at $106.0 million (up 307.69% YoY), while the FY2025 annual figure was $99.0 million, up 10.0% from the prior year.
- Other Non Operating Income came in at -$12.0 million for Q2 2026 at Iqvia Holdings, down from -$7.0 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $94.0 million in Q4 2025 to a low of -$44.0 million in Q3 2024.
- Average Other Non Operating Income over 5 years is $16.5 million, with a median of $10.0 million recorded in 2024.
- Year-over-year, Other Non Operating Income plunged 366.67% in 2022 and jumped 1150.0% in 2023.
- Over 5 years, Other Non Operating Income stood at $18.0 million in 2022, then jumped by 161.11% to $47.0 million in 2023, then jumped by 65.96% to $78.0 million in 2024, then grew by 20.51% to $94.0 million in 2025, then slumped by 112.77% to -$12.0 million in 2026.
- Per Business Quant data, the three most recent Other Non Operating Income figures were -$12.0 million in Q2 2026, -$7.0 million in Q1 2026, and $94.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -12.00 Mn |
| Mar 31, 2026 | -7.00 Mn |
| Dec 31, 2025 | 94.00 Mn |
| Sep 30, 2025 | 31.00 Mn |
| Jun 30, 2025 | -11.00 Mn |
| Mar 31, 2025 | 3.00 Mn |
| Dec 31, 2024 | 78.00 Mn |
| Sep 30, 2024 | -44.00 Mn |
| Jun 30, 2024 | 11.00 Mn |
| Mar 31, 2024 | 9.00 Mn |
| Dec 31, 2023 | 47.00 Mn |
| Sep 30, 2023 | 35.00 Mn |
| Jun 30, 2023 | 7.00 Mn |
| Mar 31, 2023 | 25.00 Mn |
| Dec 31, 2022 | 18.00 Mn |
| Sep 30, 2022 | 25.00 Mn |
| Jun 30, 2022 | -14.00 Mn |
| Mar 31, 2022 | 2.00 Mn |
| Dec 31, 2021 | 2.00 Mn |
| Sep 30, 2021 | 62.00 Mn |